TY - JOUR
T1 - A Road Map of the Axial Spondyloarthritis Continuum
AU - Schwartzman, Sergio
AU - Ruderman, Eric M.
N1 - Funding Information:
Medical writing support was provided by Richard Karpowicz, PhD, of Health Interactions, Inc, Hamilton, New Jersey, and was funded by Novartis Pharmaceuticals Corporation. This manuscript was developed in accordance with Good Publication Practice (GPP3) guidelines. Authors had full control of the content and made the final decision on all aspects of this publication.
Publisher Copyright:
© 2021 Mayo Foundation for Medical Education and Research
PY - 2022/1
Y1 - 2022/1
N2 - Axial spondyloarthritis (axSpA) is a chronic, immune-mediated inflammatory disease characterized by inflammatory low back pain, inflammation in peripheral joints and entheses, and other extra-articular or systemic manifestations. Although our understanding of the natural history of axSpA has been limited by incomplete knowledge of disease pathogenesis, axSpA is increasingly understood as a spectrum of axial, peripheral, and extra-articular inflammatory conditions that includes nonradiographic axSpA and radiographic axSpA, also known as ankylosing spondylitis. In this narrative review, we present a road map of this axSpA continuum, highlighting genetic risk factors for the development of axSpA, triggers of disease, and reasons for and implications of diagnostic delay. We present a detailed overview of the spectrum of axSpA clinical manifestations and highlight factors known to influence the risk of disease progression. Finally, we provide some expert commentary on the practical use of this road map to assist health care providers in the identification of axSpA in clinical practice.
AB - Axial spondyloarthritis (axSpA) is a chronic, immune-mediated inflammatory disease characterized by inflammatory low back pain, inflammation in peripheral joints and entheses, and other extra-articular or systemic manifestations. Although our understanding of the natural history of axSpA has been limited by incomplete knowledge of disease pathogenesis, axSpA is increasingly understood as a spectrum of axial, peripheral, and extra-articular inflammatory conditions that includes nonradiographic axSpA and radiographic axSpA, also known as ankylosing spondylitis. In this narrative review, we present a road map of this axSpA continuum, highlighting genetic risk factors for the development of axSpA, triggers of disease, and reasons for and implications of diagnostic delay. We present a detailed overview of the spectrum of axSpA clinical manifestations and highlight factors known to influence the risk of disease progression. Finally, we provide some expert commentary on the practical use of this road map to assist health care providers in the identification of axSpA in clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=85120380505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120380505&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2021.08.007
DO - 10.1016/j.mayocp.2021.08.007
M3 - Review article
C2 - 34801248
AN - SCOPUS:85120380505
SN - 0025-6196
VL - 97
SP - 134
EP - 145
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 1
ER -